peptic ulcer disease vs gastrinoma

Reading File
Finding Sources
Finding Sources
Searching PubMed

"gastrinoma" AND "peptic ulcer"

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching Images

peptic ulcer disease gastric duodenal ulcer

Diagnostic CT imaging of the abdomen and pelvis presented in coronal (A), sagittal (B), and axial (C, D) planes, demonstrating complications of peptic ulcer disease. The visual findings include severe edema of the gastric pylorus and duodenum (purple arrow), which has led to significant gastric outlet obstruction. This obstruction is evidenced by a markedly distended stomach containing retained gastric contents (orange arrows). Additionally, there is a localized area of increased soft tissue attenuation with focal gas and central necrosis, indicated by blue arrows, which suggests a contained or walled-off perforation of the duodenal wall. These images highlight the radiological features of complicated duodenal ulcers, including secondary obstructive changes and focal inflammatory masses associated with chronic perforation. This content is suitable for intermediate to advanced medical learners studying gastrointestinal pathology and radiology.

Diagnostic CT imaging of the abdomen and pelvis presented in coronal (A), sagittal (B), and axial (C, D) planes, demonstrating complications of peptic ulcer disease. The visual findings include severe edema of the gastric pylorus and duodenum (purple arrow), which has led to significant gastric outlet obstruction. This obstruction is evidenced by a markedly distended stomach containing retained gastric contents (orange arrows). Additionally, there is a localized area of increased soft tissue attenuation with focal gas and central necrosis, indicated by blue arrows, which suggests a contained or walled-off perforation of the duodenal wall. These images highlight the radiological features of complicated duodenal ulcers, including secondary obstructive changes and focal inflammatory masses associated with chronic perforation. This content is suitable for intermediate to advanced medical learners studying gastrointestinal pathology and radiology.

This endoscopic clinical photograph displays a 7 mm cratered ulcer located in the duodenal bulb, a common manifestation of peptic ulcer disease. The ulcer is characterized by a central, depressed crater filled with a brownish-gray fibrinous base and mucus. The surrounding duodenal mucosa is intensely erythematous and edematous, indicating active inflammation (duodenitis). Visible mucosal changes include a granular texture and prominent mucosal folds. Bubbles from gastric secretions are present in the foreground, indicating the fluid-rich environment of the upper gastrointestinal tract. This visual is representative of H. pylori-associated ulceration or NSAID-induced mucosal injury, providing a classic example for gastroenterology and internal medicine education regarding diagnostic upper endoscopy (esophagogastroduodenoscopy) and the morphological evaluation of duodenal lesions.

This endoscopic clinical photograph displays a 7 mm cratered ulcer located in the duodenal bulb, a common manifestation of peptic ulcer disease. The ulcer is characterized by a central, depressed crater filled with a brownish-gray fibrinous base and mucus. The surrounding duodenal mucosa is intensely erythematous and edematous, indicating active inflammation (duodenitis). Visible mucosal changes include a granular texture and prominent mucosal folds. Bubbles from gastric secretions are present in the foreground, indicating the fluid-rich environment of the upper gastrointestinal tract. This visual is representative of H. pylori-associated ulceration or NSAID-induced mucosal injury, providing a classic example for gastroenterology and internal medicine education regarding diagnostic upper endoscopy (esophagogastroduodenoscopy) and the morphological evaluation of duodenal lesions.

This diagnostic comparison chart displays four gastroscopic images documenting the healing progression of peptic ulcers. The images are arranged in a 2x2 grid, categorized by anatomical location (antrum of stomach and duodenal bulb) and timeline (start vs. 2 months later). The 'start' images reveal significant mucosal injury: the gastric antrum shows a deep, large ulcer with surrounding mucosal erosions, while the duodenal bulb demonstrates a prominent ulcer with central green slough and erythematous, inflamed surrounding tissue. The '2 months later' images, following treatment with a proton pump inhibitor (omeprazole), illustrate substantial healing. In the gastric antrum, the ulcer has markedly decreased in size with smoothing of the adjacent mucosa. In the duodenal bulb, the ulcer has completely resolved, replaced by a red linear scar and healthy regenerative epithelium. This visual evidence highlights the efficacy of pharmacologic intervention in treating NSAID-related (aspirin-induced) peptic ulcer disease and the capacity for mucosal recovery over a two-month period.

This diagnostic comparison chart displays four gastroscopic images documenting the healing progression of peptic ulcers. The images are arranged in a 2x2 grid, categorized by anatomical location (antrum of stomach and duodenal bulb) and timeline (start vs. 2 months later). The 'start' images reveal significant mucosal injury: the gastric antrum shows a deep, large ulcer with surrounding mucosal erosions, while the duodenal bulb demonstrates a prominent ulcer with central green slough and erythematous, inflamed surrounding tissue. The '2 months later' images, following treatment with a proton pump inhibitor (omeprazole), illustrate substantial healing. In the gastric antrum, the ulcer has markedly decreased in size with smoothing of the adjacent mucosa. In the duodenal bulb, the ulcer has completely resolved, replaced by a red linear scar and healthy regenerative epithelium. This visual evidence highlights the efficacy of pharmacologic intervention in treating NSAID-related (aspirin-induced) peptic ulcer disease and the capacity for mucosal recovery over a two-month period.

Reading File
Searching Images

gastrinoma Zollinger-Ellison syndrome pancreatic neuroendocrine tumor

Histopathology image of a gastroenteropancreatic neuroendocrine tumor (gastrinoma) evaluated on hematoxylin and eosin stain. The tumor is composed of uniform nests and cords of neuroendocrine cells embedded in dense fibrous stroma with conspicuous fibrous septa. Cells are polygonal with round to oval nuclei and granular (salt-and-pepper) nuclear chromatin; cytoplasm is moderate to scant, with low mitotic activity. Architectural pattern shows cohesive clusters separated by desmoplastic stroma rather than mucosal nodules with tightly packed trabeculae and acini typical of Type 2 gastrinomas. In this case the desmoplastic reaction may contribute to firm, fibrous tissue surrounding tumor nodules. Immunohistochemistry (not shown) would commonly be positive for chromogranin A and synaptophysin, supporting neuroendocrine differentiation, and gastrin production in clinically suspected Zollinger-Ellison syndrome or MEN1. Clinically, gastrin-secreting tumors cause hypergastrinemia, peptic ulcers, and refractory ulcers; they are part of the MEN1 spectrum. Pathologic differential includes well-differentiated neuroendocrine tumor versus poorly differentiated neuroendocrine carcinoma and pancreatic ductal adenocarcinoma with desmoplasia; architectural and cytologic features favor NET. The image highlights important diagnostic clues: neuroendocrine cytology, uniform cell morphology, nesting patterns, and desmoplastic stroma, guiding clinical correlation and management. This histologic pattern informs prognosis, surgical planning, and consideration of somatostatin receptor-targeted therapies in NETs. Moreover, it guides clinical management.

Histopathology image of a gastroenteropancreatic neuroendocrine tumor (gastrinoma) evaluated on hematoxylin and eosin stain. The tumor is composed of uniform nests and cords of neuroendocrine cells embedded in dense fibrous stroma with conspicuous fibrous septa. Cells are polygonal with round to oval nuclei and granular (salt-and-pepper) nuclear chromatin; cytoplasm is moderate to scant, with low mitotic activity. Architectural pattern shows cohesive clusters separated by desmoplastic stroma rather than mucosal nodules with tightly packed trabeculae and acini typical of Type 2 gastrinomas. In this case the desmoplastic reaction may contribute to firm, fibrous tissue surrounding tumor nodules. Immunohistochemistry (not shown) would commonly be positive for chromogranin A and synaptophysin, supporting neuroendocrine differentiation, and gastrin production in clinically suspected Zollinger-Ellison syndrome or MEN1. Clinically, gastrin-secreting tumors cause hypergastrinemia, peptic ulcers, and refractory ulcers; they are part of the MEN1 spectrum. Pathologic differential includes well-differentiated neuroendocrine tumor versus poorly differentiated neuroendocrine carcinoma and pancreatic ductal adenocarcinoma with desmoplasia; architectural and cytologic features favor NET. The image highlights important diagnostic clues: neuroendocrine cytology, uniform cell morphology, nesting patterns, and desmoplastic stroma, guiding clinical correlation and management. This histologic pattern informs prognosis, surgical planning, and consideration of somatostatin receptor-targeted therapies in NETs. Moreover, it guides clinical management.

This diagnostic image is a contrast-enhanced axial (transverse) computed tomography (CT) scan of the upper abdomen. The visualization shows a cross-section of the abdominal cavity with anatomical landmarks including the liver (right), pancreas (central), kidneys (bilateral posterior), and the vertebral body of the spine. Red arrows highlight significant clinical findings: one arrow indicates a hyperenhancing mass located within the pancreatic head, identified as a primary gastrinoma (Zollinger-Ellison syndrome). A second arrow identifies a focal lesion within the hepatic parenchyma, consistent with metastatic disease. The image demonstrates the relationship between primary neuroendocrine tumors and their secondary spread. The surrounding soft tissues, retroperitoneal space, and bowel loops are also visible, providing context for tumor localization and staging. This visual is intended for medical education regarding the diagnostic imaging of pancreatic neuroendocrine tumors and their common metastatic patterns to the liver.

This diagnostic image is a contrast-enhanced axial (transverse) computed tomography (CT) scan of the upper abdomen. The visualization shows a cross-section of the abdominal cavity with anatomical landmarks including the liver (right), pancreas (central), kidneys (bilateral posterior), and the vertebral body of the spine. Red arrows highlight significant clinical findings: one arrow indicates a hyperenhancing mass located within the pancreatic head, identified as a primary gastrinoma (Zollinger-Ellison syndrome). A second arrow identifies a focal lesion within the hepatic parenchyma, consistent with metastatic disease. The image demonstrates the relationship between primary neuroendocrine tumors and their secondary spread. The surrounding soft tissues, retroperitoneal space, and bowel loops are also visible, providing context for tumor localization and staging. This visual is intended for medical education regarding the diagnostic imaging of pancreatic neuroendocrine tumors and their common metastatic patterns to the liver.

I now have comprehensive information from multiple authoritative textbooks. Let me compile the full detailed comparison.

Peptic Ulcer Disease vs. Gastrinoma (Zollinger-Ellison Syndrome)


Overview

Peptic Ulcer Disease (PUD) is a very common condition - more than 4 million patients treated annually in the US - defined by ulceration of the gastric or duodenal mucosa due to an imbalance between mucosal protective and damaging forces. Gastrinoma (causing Zollinger-Ellison Syndrome, ZES) is a rare neuroendocrine tumor that autonomously secretes gastrin, driving massive, unregulated gastric acid hypersecretion and causing severe, often refractory, or atypically located ulcers. Gastrinoma accounts for fewer than 0.5% of all gastroduodenal ulcers.

Pathophysiology Comparison

FeaturePUDGastrinoma (ZES)
Core mechanismImbalance: mucosal defense vs. acid/pepsin damageAutonomous gastrin hypersecretion → unregulated acid overproduction
Gastrin levelNormal or mildly elevatedMarkedly elevated (often >10x ULN)
Parietal cell massNormal or mildly increasedGreatly increased (gastrin is trophic to parietal cells)
Acid secretionNormal to moderately elevatedMassively elevated; BAO often >15 mEq/h
Feedback inhibitionGastrin secretion normally suppressed by luminal acidTumor-derived gastrin NOT inhibited by acid - secretion continues unabated
H. pylori roleMajor cause (>70% of cases); damages mucosa, inhibits somatostatin → increased gastrin → more acidCan coexist but is not the primary driver
NSAID roleMajor cause (especially gastric ulcers); inhibit prostaglandin E2, impair mucosal barrierNot a primary driver

Physiology of the Defect

In normal acid regulation, G cells in the antrum release gastrin in response to meals; gastrin stimulates parietal cells (via CCK-B receptor) and ECL cells (via histamine) to secrete HCl; rising acid then triggers D cell somatostatin release, which feedbacks to suppress both gastrin and histamine. This control loop is intact in PUD.
In gastrinoma, the tumor G cells secrete gastrin constitutively and are insensitive to acid feedback. The result is persistent parietal cell stimulation, markedly increased parietal cell mass, and acid output that overwhelms the neutralizing capacity of duodenal bicarbonate - eroding mucosa far beyond the normal duodenal bulb and even into the jejunum. - Costanzo Physiology 7th Edition, p. 370

Clinical Features Comparison

FeaturePUDGastrinoma (ZES)
PrevalenceVery common; lifetime risk ~10% (M), ~4% (F)Rare; <0.5% of peptic ulcers
Age of onsetAny age; increasing >60 yrsTypically 30-50 years
SexM slightly > FMen 60%
Ulcer numberUsually solitary (>80% of cases)Often multiple
Ulcer locationGastric antrum / proximal duodenum (within a few cm of pyloric valve)Multiple in duodenum AND stomach; can involve jejunum (atypical - red flag)
Response to therapyGood response to PPIs + H. pylori eradicationRefractory to standard therapy - a key red flag
DiarrheaUncommonPresent in 70% of patients as initial symptom (secretory + osmotic, from acid inactivating pancreatic enzymes)
SteatorrheaUncommonYes - low duodenal pH inactivates pancreatic lipase; fat malabsorption
Gastric foldsNormalThickened gastric folds on endoscopy (94% of cases)
ComplicationsBleeding, perforation, obstructionSame + hepatic metastases (>50% malignant at diagnosis)
Associated syndromes-MEN-1 (Werner syndrome) in ~25%; multifocal tumors

Morphology

PUD

  • Solitary (>80%), round to oval, "punched-out" defect with smooth, clean base (peptic digestion of exudate)
  • Sharp margins, level with surrounding mucosa (heaped-up margins suggest cancer)
  • Most common: proximal duodenum (a few cm from pylorus) and gastric lesser curvature (body-antrum junction)
  • Histology: fibrinoid debris + neutrophils acutely; granulation tissue + fibrous scar chronically
  • Robbins, Cotran & Kumar Pathologic Basis of Disease
Duodenal ulcer on endoscopy - cratered lesion with fibrinous base and surrounding erythema

Gastrinoma

  • Tumor itself: uniform nests/cords of neuroendocrine cells with "salt-and-pepper" chromatin; bland histology; desmoplastic stroma; IHC positive for chromogranin A, synaptophysin, and gastrin
  • More than half are locally invasive or metastatic at diagnosis; 60% are malignant
  • Sporadic gastrinomas: usually single; MEN-1 associated: frequently multifocal
  • Located in the "gastrinoma triangle": pancreas, duodenum, peripancreatic soft tissues
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 1028
CT scan showing hyperenhancing pancreatic head gastrinoma with hepatic metastasis
Histopathology of gastrinoma - neuroendocrine nests with salt-and-pepper chromatin

Diagnosis

When to Suspect Gastrinoma Over PUD

These are the red flags for ZES that should prompt workup:
  • Ulcers refractory to standard PPI therapy
  • Multiple or recurrent ulcers
  • Ulcers in atypical locations (distal duodenum, jejunum)
  • Unexplained secretory diarrhea or steatorrhea
  • Prominent gastric rugal folds on endoscopy/imaging
  • PUD + family history of MEN-1 (pituitary, parathyroid, pancreatic tumors)
  • Hypercalcemia (from MEN-1 hyperparathyroidism stimulating gastrin)

Diagnostic Workup for ZES

TestDetailsInterpretation
Fasting serum gastrinFirst-line; must stop PPI for ≥7 days before testing (substitute H2 blocker, stop 24h prior)Normal <150 pg/mL; ZES typically >150-200 pg/mL; >10x ULN (e.g., >1000 pg/mL) + acid hypersecretion = virtually diagnostic
Gastric pH / BAOGastric aspirate pH; Basal Acid OutputpH <3 suggestive; BAO >15 mEq/h + hypergastrinemia = pathognomonic of ZES
Secretin stimulation testGold standard provocative test; IV secretin 2 U/kg bolus, gastrin measured before and afterIn ZES: paradoxical rise in gastrin ≥120 pg/mL above baseline (normally secretin inhibits gastrin); sensitivity and specificity superior to calcium infusion test
Calcium infusion testOlder test; less sensitive/specific than secretinLess preferred
EndoscopyLook for multiple ulcers, thickened folds, jejunal ulcers94% of ZES have thickened gastric folds
Imaging (CT/MRI/EUS/Octreoscan)Localize tumorSomatostatin receptor scintigraphy (Octreoscan) most sensitive for metastases
H. pylori testingUrea breath test, stool antigen, biopsy CLO testPositive in PUD; can coexist in ZES but not primary driver
Important caveat on fasting gastrin: Mildly elevated gastrin can be seen in PPI use, achlorhydria, pernicious anemia, H. pylori infection, G-cell hyperplasia, chronic renal failure, and gastric outlet obstruction. Two-thirds of ZES patients have gastrin levels that overlap with these common causes. Context (acid secretion + clinical picture) is essential. - Harrison's Principles of Internal Medicine 22E, 2025
Why does secretin paradoxically increase gastrin in ZES? Under normal physiology, secretin (released from duodenal S cells in response to luminal acid) inhibits gastrin release from antral G cells. In gastrinoma, tumor G cells lack the receptor mechanism for secretin-mediated suppression - instead, secretin stimulates the tumor cells to release even more gastrin. This forms the biological basis of the secretin stimulation test. - Yamada's Textbook of Gastroenterology 7th ed.

Treatment Comparison

AspectPUDGastrinoma (ZES)
Acid suppressionPPI (first-line); H2 blockersHigh-dose PPI (H+/K+-ATPase inhibitors) - often require doses 2-3x standard
H. pylori eradicationTriple/quadruple therapy if H. pylori positive; essentialTreat if present; does not cure ZES
SurgeryRarely needed (for complications: perforation, bleeding, obstruction)Resection of the tumor when localized; total gastrectomy historically (now replaced by medical acid suppression)
Tumor-targeted therapyN/ASurgical resection (potentially curative in sporadic, non-metastatic disease); somatostatin analogs (octreotide) for symptom control; chemotherapy/targeted therapy for metastatic disease
PrognosisExcellent with treatmentDepends on tumor extent; hepatic metastases = shortened life expectancy (often <10 years with progressive liver failure)

Key Distinguishing Summary Table

FeaturePUDGastrinoma (ZES)
FrequencyVery commonRare
EtiologyH. pylori, NSAIDsGastrin-secreting neuroendocrine tumor
Fasting gastrinNormalMarkedly elevated
Ulcer locationsDuodenal bulb, gastric antrumMultiple; distal duodenum, jejunum
Response to PPIsGoodRefractory / requires high-dose
Diarrhea/steatorrheaUncommonCommon (70%); due to acid-inactivated pancreatic enzymes
Secretin testGastrin falls/unchangedParadoxical gastrin rise ≥120 pg/mL
MalignancyUlcer itself is not malignant (but gastric ulcers need biopsy to exclude cancer)Tumor itself: >60% malignant
AssociationH. pylori, NSAIDs, smokingMEN-1 (25% of cases)

Sources: Robbins, Cotran & Kumar Pathologic Basis of Disease | Costanzo Physiology 7th Edition | Harrison's Principles of Internal Medicine 22E (2025) | Tietz Textbook of Laboratory Medicine 7th Edition | Yamada's Textbook of Gastroenterology 7th Edition | Robbins & Kumar Basic Pathology
This is a shared conversation. Sign in to Orris to start your own chat.